Twin Peaks Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Twin Peaks Wealth Advisors's PFE Position: Q2 2026 in Review
Twin Peaks Wealth Advisors sold out of Pfizer (PFE) in Q2 2026, closing a stake of 5,363 shares — an estimated $151K sold.
Twin Peaks Wealth Advisors first reported a position in PFE in Q4 2023 and held it in 3 quarters. The position peaked at $212K in Q4 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Twin Peaks Wealth Advisors reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Twin Peaks Wealth Advisors sold 5,363 Pfizer shares in Q2 2026, an estimated $151K.
- Twin Peaks Wealth Advisors first reported a position in Pfizer in Q4 2023 and held it in 3 quarters.
- Twin Peaks Wealth Advisors's Pfizer position peaked at $212K in Q4 2023.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.